Pharma/Generic/Biotech Perspectives | Specialty Pharma/Drug Delivery Insights | Financial/Venture Capital/M&A Trends | Academic/Health Plan/Consulting/Legal Perspectives |
ADAMS RESPIRATORY THERAPEUTICS AMGEN AMYLIN PHARMACEUTICALS BAYER HEALTHCARE BRISTOL-MYERS SQUIBB BROOKWOOD PHARMACEUTICALS GENZYME GLIDE PHARMA HALOZYME THERAPEUTICS MANNKIND CORPORATION MERCK & Co., Inc. NOVO NORDISK NOVARTIS PENWEST PURDUE PHARMA REDPOINT BIO CORPORATION ROCHE UPSHER-SMITH LABORATORIES WYETH | 3M DRUG DELIVERY ALTEA THERAPEUTICS ARADIGM AVEVA DDS BANNER BEND RESEARCH BIOMIMETIC CHARLESSON PHARMACEUTICALS DURECT CORPORATION ELAN DRUG TECHNOLOGIES ENDO PHARMA EURAND JAVELIN PHARMA PANTEC BIOSOLUTIONS SKYE PHARMA VICTORY PHARMA ZOGENIX | AISLING CAPITAL BIONUMBERS DEUTSCHE BANK FRAZIER PAPPAS VENTURES SR ONE STONECROFT CAPITAL | BILL & MELINDA GATES FOUNDATION DAVIDSON DAVIDSON & KAPPEL HEALTHCARE ECONOMICS, LLC RUTGERS UNIVERSITY VALEO PARTNERS VALEO PARTNERS UNIVERSITY OF CALIFORNIA- BERKELEY |